BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19486339)

  • 1. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
    Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
    Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q; Wang G; Zhang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
    Yang J; Zhou F; Xu T; Deng H; Ge YY; Zhang C; Li J; Zhuang SM
    Mutat Res; 2008 Feb; 638(1-2):205-9. PubMed ID: 17900631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
    Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
    Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.
    Shen G; Jia H; Tai Q; Li Y; Chen D
    Carcinogenesis; 2013 Jan; 34(1):211-9. PubMed ID: 23087084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
    Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
    Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
    Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
    Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.
    Fang L; Deng Z; Shatseva T; Yang J; Peng C; Du WW; Yee AJ; Ang LC; He C; Shan SW; Yang BB
    Oncogene; 2011 Feb; 30(7):806-21. PubMed ID: 20956944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
    Hui AB; Lenarduzzi M; Krushel T; Waldron L; Pintilie M; Shi W; Perez-Ordonez B; Jurisica I; O'Sullivan B; Waldron J; Gullane P; Cummings B; Liu FF
    Clin Cancer Res; 2010 Feb; 16(4):1129-39. PubMed ID: 20145181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
    Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
    Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
    Wong TS; Liu XB; Wong BY; Ng RW; Yuen AP; Wei WI
    Clin Cancer Res; 2008 May; 14(9):2588-92. PubMed ID: 18451220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
    J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
    Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
    Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
    Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
    Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.